These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23229715)

  • 1. Nasolacrimal duct obstruction resolution.
    Macewen CJ
    Arch Ophthalmol; 2012 Dec; 130(12):1623-4. PubMed ID: 23229715
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital nasolacrimal duct obstruction: the proper technique of massage.
    Shivpuri D; Puri A
    Indian Pediatr; 1994 Mar; 31(3):337-40. PubMed ID: 7896374
    [No Abstract]   [Full Text] [Related]  

  • 3. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Jun; 130(6):730-4. PubMed ID: 22801833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.
    Karti O; Karahan E; Acan D; Kusbeci T
    Int Ophthalmol; 2016 Dec; 36(6):845-849. PubMed ID: 26948127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage.
    Noda S; Hayasaka S; Setogawa T
    J Pediatr Ophthalmol Strabismus; 1991; 28(1):20-2. PubMed ID: 2019953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Different managements of congenital nasolacrimal duct obstruction].
    Ma QY; Chen YZ; Liu AQ
    Yan Ke Xue Bao; 1985 Dec; 1(2):129-32. PubMed ID: 3880145
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital tear duct obstruction.
    David ML; Collins JW
    Am Fam Physician; 1984 Jan; 29(1):213-8. PubMed ID: 6695645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic therapy in congenital obstruction of the nasolacrimal duct].
    Nucci P
    Minerva Pediatr; 1990 May; 42(5):189-91. PubMed ID: 2381391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crigler Massage for Congenital Blockade of Nasolacrimal Duct.
    Durrani J
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):145-148. PubMed ID: 28406772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents.
    Song HY; Jin YH; Kim JH; Sung KB; Han YM; Cho NC
    Radiology; 1994 Feb; 190(2):535-9. PubMed ID: 8284412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting treatment outcome in congenital nasolacrimal duct obstruction: A retrospective analysis from South India.
    Bhandari S; Sengupta S; Yadalla D; Rajagopalan J; Velis GB; Talele D; Kushwaha S
    Indian J Ophthalmol; 2015 Oct; 63(10):759-62. PubMed ID: 26654998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaporin expression in the lacrimal sac of patients with primary and functional nasolacrimal duct obstruction.
    Park J; Kim J; Kim M; Baek S
    Br J Ophthalmol; 2017 Apr; 101(4):519-524. PubMed ID: 27439740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rosenmüller valve during endoscopic dacryocystorhinostomy in treating refractory nasolacrimal duct obstruction].
    Wang M; Wang SQ; Zhang J; Li MW; Xing ZM; Yuan XP; Li H; Liu Y; Geng CL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):522-7. PubMed ID: 27480301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
    Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
    Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and management of congenital nasolacrimal duct obstruction.
    Kapadia MK; Freitag SK; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):959-77, vii. PubMed ID: 16982257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the treatment for nasolacrimal duct obstruction].
    Zhang Q; Qian Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):108-9. PubMed ID: 11593619
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital nasolacrimal duct obstruction: Should we continue lacrimal massage till 1 year or perform an office probing at 6 months? A clinical decision analysis approach.
    Kothari M; Rathod V; Shah K; Shikhangi K; Singhania R
    Indian J Ophthalmol; 2017 Feb; 65(2):167-169. PubMed ID: 28345576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.